Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 4/2018

11.01.2018 | Short Communication

A Very Rare Case with Particular H-deficient Phenotypes

verfasst von: Min Song, Shuming Zhao, Tianlun Jiang, Hua Lu

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Bombay phenotype, H partially deficient non secretor phenotype and Para-Bombay phenotype are rare blood groups with deficiency or absence of H antigen. A 52-year-old female with Chronic suppurative otitis media was referred to our hospital. The primary serologic results of ABO blood typing were discrepant in forward and reverse grouping. Further, the saliva secretion tests, the pedigree studies and the sequence analysis were performed to confirm the rare phenotype. The patient was diagnosed as a variant H-deficient phenotype, secretor (para-bombay). Red cells of the patient have no H antigens, and it’s a very interesting thing that there were two opposite results in the saliva test by using different anti-H. The test showed that H substances were present in the saliva by using anti-H from Libo Biotechnology Co, while which were absent by using anti-H from Shanghai blood center. The patient’s Lewis phenotype was Le (a−b+). Anti-HI was present in the sera of her. The sequence of the ABO gene of the patient was 261delG and 467C>T heterozygote by direct DNA sequencing and was assigned as A102/O01. There were two mutations of the patient’s FUT1, 328G/A and 658C/T, which were identified by DNA sequencing compared with the reference sequence (GenBank, NG_007510.2). In this case, we report a patient with particular H-deficient phenotype, secretor, which showed opposite results in the saliva test by using anti-H from different sources. We suspect that it is a variant of para-Bombay phenotype.
Literatur
1.
Zurück zum Zitat Kelly RJ, Rouquier S, Giorgi D et al (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649CrossRef Kelly RJ, Rouquier S, Giorgi D et al (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649CrossRef
2.
Zurück zum Zitat Rouquier S, Lowe JB, Kelly RJ et al (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270:4632–4639CrossRef Rouquier S, Lowe JB, Kelly RJ et al (1995) Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 270:4632–4639CrossRef
3.
Zurück zum Zitat Daniels G (2002) Human blood groups, 2nd edn. Blackwell Science, MaldenCrossRef Daniels G (2002) Human blood groups, 2nd edn. Blackwell Science, MaldenCrossRef
4.
Zurück zum Zitat Geng W, Gao HH, Zhang LW (2016) Serological characteristics and family survey of 3 cases of H-deficient blood group. Zhongguo shi yan xue ye xue za zhi 24:913–917PubMed Geng W, Gao HH, Zhang LW (2016) Serological characteristics and family survey of 3 cases of H-deficient blood group. Zhongguo shi yan xue ye xue za zhi 24:913–917PubMed
5.
Zurück zum Zitat Maeda H, Ohshima T, Takayasu T, Tanaka N (1985) A case of para-Bombay phenotype Bhm (OBHm). Nihon Hoigaku Zasshi 39:209–213PubMed Maeda H, Ohshima T, Takayasu T, Tanaka N (1985) A case of para-Bombay phenotype Bhm (OBHm). Nihon Hoigaku Zasshi 39:209–213PubMed
6.
Zurück zum Zitat Malhotra S, Dhawan HK, Jain A et al (2014) Acute hemolytic transfusion reaction in a patient with bombay phenotype: implications for ABO grouping. Indian J Hematol Blood Transfus 30:108–110CrossRef Malhotra S, Dhawan HK, Jain A et al (2014) Acute hemolytic transfusion reaction in a patient with bombay phenotype: implications for ABO grouping. Indian J Hematol Blood Transfus 30:108–110CrossRef
7.
Zurück zum Zitat Shrivastava M, Navaid S, Peethambarakshan A et al (2015) Detection of rare blood group, Bombay (Oh) phenotype patients and management by acute normovolemic hemodilution. Asian J Transfus Sci 9:74–77CrossRef Shrivastava M, Navaid S, Peethambarakshan A et al (2015) Detection of rare blood group, Bombay (Oh) phenotype patients and management by acute normovolemic hemodilution. Asian J Transfus Sci 9:74–77CrossRef
8.
Zurück zum Zitat Seifinejad A, Taei A, Totonchi M et al (2010) Generation of human induced pluripotent stem cells from a Bombay individual: moving towards “universal-donor” red blood cells. Biochem Biophys Res Commun 391:329–334CrossRef Seifinejad A, Taei A, Totonchi M et al (2010) Generation of human induced pluripotent stem cells from a Bombay individual: moving towards “universal-donor” red blood cells. Biochem Biophys Res Commun 391:329–334CrossRef
9.
Zurück zum Zitat Kelly RJ, Rouquier S, Giorgi D et al (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649CrossRef Kelly RJ, Rouquier S, Giorgi D et al (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270:4640–4649CrossRef
10.
Zurück zum Zitat Dipta TF, Hossain AZ (2011) The Bombay blood group: Are we out of risk? Mymensingh Med J 20:536–540PubMed Dipta TF, Hossain AZ (2011) The Bombay blood group: Are we out of risk? Mymensingh Med J 20:536–540PubMed
11.
Zurück zum Zitat Le Pendu J, Gerard G, Vitrac D et al (1983) H-deficient blood groups of Reunion island. II. Differences between Indians (Bombay Phenotype) and whites (Reunion phenotype). Am J Hum Genet 35:484–496PubMedPubMedCentral Le Pendu J, Gerard G, Vitrac D et al (1983) H-deficient blood groups of Reunion island. II. Differences between Indians (Bombay Phenotype) and whites (Reunion phenotype). Am J Hum Genet 35:484–496PubMedPubMedCentral
12.
Zurück zum Zitat Su Y, Wei TL, Yu Q et al (2007) Molecular genetic analysis of FUT1 and FUT2 gene in para-Bombay Chinese: a novel FUT1 allele is identified. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:520–523PubMed Su Y, Wei TL, Yu Q et al (2007) Molecular genetic analysis of FUT1 and FUT2 gene in para-Bombay Chinese: a novel FUT1 allele is identified. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24:520–523PubMed
13.
Zurück zum Zitat Xu DY, Deng G, Huang DD, Zhao WJ (2011) Mutational analysis for FUT1 gene in two cases with para-Bombay blood type. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28:694–698PubMed Xu DY, Deng G, Huang DD, Zhao WJ (2011) Mutational analysis for FUT1 gene in two cases with para-Bombay blood type. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28:694–698PubMed
14.
Zurück zum Zitat Sun CF, Lo MD, Lee CH, Chu DC (2000) Novel mutations, including a novel G659A missense mutation, of the FUT1 gene are responsible for the para-Bombay phenotype. Ann Clin Lab Sci 30:387–390PubMed Sun CF, Lo MD, Lee CH, Chu DC (2000) Novel mutations, including a novel G659A missense mutation, of the FUT1 gene are responsible for the para-Bombay phenotype. Ann Clin Lab Sci 30:387–390PubMed
15.
Zurück zum Zitat Zhang X, Li J (2016) Ael subgroup due to alpha-1,3-N-acetylgalactoseaminotransferase gene 467C>T and 804insG variants. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 33:526–529PubMed Zhang X, Li J (2016) Ael subgroup due to alpha-1,3-N-acetylgalactoseaminotransferase gene 467C>T and 804insG variants. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 33:526–529PubMed
16.
Zurück zum Zitat Lin F, Sun C, Wang H et al (2015) Study of a case with homozygous 35C>T and 658C>T mutations of FUT1 gene leading to a para-Bombay phenotype. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 32:834–836PubMed Lin F, Sun C, Wang H et al (2015) Study of a case with homozygous 35C>T and 658C>T mutations of FUT1 gene leading to a para-Bombay phenotype. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 32:834–836PubMed
17.
Zurück zum Zitat Luo G, Wei L, Wang Z et al (2013) The summary of FUT1 and FUT2 genotyping analysis in Chinese para-Bombay individuals including additional nine probands from Guangzhou in China. Transfusion 53:3224–3229CrossRef Luo G, Wei L, Wang Z et al (2013) The summary of FUT1 and FUT2 genotyping analysis in Chinese para-Bombay individuals including additional nine probands from Guangzhou in China. Transfusion 53:3224–3229CrossRef
18.
Zurück zum Zitat Yamamoto F, Clausen H, White T et al (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345:229–233CrossRef Yamamoto F, Clausen H, White T et al (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345:229–233CrossRef
19.
Zurück zum Zitat Kaneko M, Nishihara S, Shinya N et al (1997) Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme. Blood 90:839–849PubMed Kaneko M, Nishihara S, Shinya N et al (1997) Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme. Blood 90:839–849PubMed
20.
Zurück zum Zitat Darabi K, Makar RS (2008) Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 48:964–968CrossRef Darabi K, Makar RS (2008) Acute hemolysis of transfused A2 red cells by an auto-HI antibody. Transfusion 48:964–968CrossRef
21.
Zurück zum Zitat Campbell SA, Shirey RS, King KE, Ness PM (2000) An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 40:828–831CrossRef Campbell SA, Shirey RS, King KE, Ness PM (2000) An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease. Transfusion 40:828–831CrossRef
22.
Zurück zum Zitat Irani MS, Richards C (2011) Hemolytic transfusion reaction due to anti-IH. Transfusion 51:2676–2678CrossRef Irani MS, Richards C (2011) Hemolytic transfusion reaction due to anti-IH. Transfusion 51:2676–2678CrossRef
Metadaten
Titel
A Very Rare Case with Particular H-deficient Phenotypes
verfasst von
Min Song
Shuming Zhao
Tianlun Jiang
Hua Lu
Publikationsdatum
11.01.2018
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2018
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-0915-3

Weitere Artikel der Ausgabe 4/2018

Indian Journal of Hematology and Blood Transfusion 4/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.